Pharmaceuticals, Biotechnology and Life Sciences
BOSTON–(BUSINESS WIRE)–Spirita Oncology, LLC, has initiated a Phase 1 clinical trial of anti-cancer agent E6201 in combination with dabrafenib in…
DUBLIN–(BUSINESS WIRE)–The “Global Ampoules and Vials Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering.…
MADISON, Wis.–(BUSINESS WIRE)–Nimble Therapeutics, an industry-leading peptide therapeutics company, today announced the appointment of Pete Gough, D. Phil. as Chief…
Company is investigating advanced therapies for the treatment of cancer, degenerative diseases, and immune and infectious diseases Participation in FII…
Competition To Focus On Improving Diverse Patients’ Access to Treatment And Responses to Treatment for Antimicrobial Resistance PARSIPPANY, N.J.–(BUSINESS WIRE)–Melinta…
Frost & Sullivan honors Clarify Health with the 2022 New Product Innovation Award SAN FRANCISCO–(BUSINESS WIRE)–For the third time this…
DALLAS–(BUSINESS WIRE)–NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS…
Vistagen to conduct small U.S. Phase 1 trial with newly optimized formulation of PH10 in Q1 2023 to confirm favorable…
– Phase 1a clinical trial of OLX-07010, a novel oral, small molecule inhibitor of tau self-association, expected to start in…
KGK has submitted a clinical trial application for Phase IIa clinical trial to test the efficacy of psilocybin on Fragile…